SEC Form 4 · accession 0000899243-16-022676
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Lee
Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 13, 2016 · 8:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2016 | A | 6,086 | $0.00 | A | 114,527 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $16.43 | Jun 9, 2016 | A | 25,827 | A | — | Jun 9, 2021 | Common Stock | 25,827 | 25,827 | D |
Explanation of responses
- F1The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 9, 2017.
- F2All of the shares subject to the option vest on June 9, 2017.